ULIHF (United Laboratories International Holdings) YoY EPS Growth : -19.27% (As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is United Laboratories International Holdings YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. United Laboratories International Holdings's YoY EPS Growth for the quarter that ended in Dec. 2024 was -19.27%.

United Laboratories International Holdings's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was $0.09.

United Laboratories International Holdings YoY EPS Growth Historical Data

The historical data trend for United Laboratories International Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings YoY EPS Growth Chart

United Laboratories International Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

Get a 7-Day Free Trial

8.93

37.70

48.81

66.40

-3.37

United Laboratories International Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EPS Growth	Get a 7-Day Free Trial															141.94	90.38	45.33	14.14	-19.27

United Laboratories International Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

United Laboratories International Holdings's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(0.201	-	0.208)	/	\| 0.208 \|
=	-3.37 %

United Laboratories International Holdings's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (Q: Dec. 2024 )
=	(Earnings per Share (Diluted) (Q: Dec. 2024 )	-	Earnings per Share (Diluted) (Q: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2023 )) \|
=	(0.088	-	0.109)	/	\| 0.109 \|
=	-19.27 %

United Laboratories International Holdings YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

United Laboratories International Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (OTCPK:ULIHF) » Definitions » YoY EPS Growth

Traded in Other Exchanges

03933:Hong Kong UNJ:Germany

Address

No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG

Website

http://www.tul.com.cn

United Laboratories International Holdings Ltd is a drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Majority of the company's sales are generated in China, followed by Europe, India and other countries.

United Laboratories International Holdings Headlines

No Headlines